期刊文献+

生长激素释放肽对心衰大鼠心肌组织中IL-6的影响 被引量:5

The effect of GHRP on the content of IL-6 in myocardium of rats with heart failure
暂未订购
导出
摘要 目的研究心肌组织中白细胞介素-6(interleukin-6,IL-6)的含量变化以及生长激素释放肽(growth hormonereleasing peptide,GHRP)对其影响。方法以阿霉素制备大鼠心衰模型,采用放射免疫学方法检测大鼠心肌组织中IL-6的含量。结果模型组与正常组相比,左室峰压、左室压力最大上升和下降速率(±dp/dtmax)降低,而心肌组织中IL-6含量增高,差异均有统计学意义(P<0.05);治疗组与模型组相比,左室峰压、左室压力最大上升和下降速率(±dp/dtmax)增高,心肌组织中IL-6含量降低,差异均有统计学意义(P<0.05),而与正常组相比差异无统计学意义(P>0.05)。结论IL-6与CHF的发生密切相关,GHRP具有降低心肌组织中IL-6含量和改善CHF大鼠心功能的作用。 Objective To study the change of the content of IL-6 in myocardium and the effect of GHRP on which. Methods Rat model of heart failure was prepared by injecting Adriamycin, and measure the content of IL-6 in myocardium of rats by Radioimmunoassay. Results Compared with normal group, the left ventricular peak pressure, left ventricular pressure maximal rising and falling rate of model group decreased, and the content of IL-6 of model group in myocardium increased. The differences were statistically significant. Compared with model group, the left ventricular peak pressure, left ventricular pressure maximal rising and falling rate of treatment group increased, and the content of IL-6 of treatment group in myocardium decreased. The differences between treatment group and model group were statistically significant. The differences between treatment group and normal group were not statistically significant. Conclusion The development of CHF is closely related to IL-6. GHRP can decrease the content of IL-6 in myocardium and improve heart function of rats with CHF.
出处 《解剖学研究》 CAS 2007年第3期186-188,194,共4页 Anatomy Research
基金 黑龙江省教育厅研究生创新科研项目(YJSCX2007-0077HLJ) 黑龙江省自然科学基金(D2006-24) 黑龙江省卫生厅重点科研项目(2005-350)
关键词 阿霉素 生长素释放肽 慢性心力衰竭 白细胞介素-6 大鼠 Adriamycin Growth hormone releasing peptide Chronic heart failure Interleukin-6 Rat
  • 相关文献

参考文献19

  • 1薛礼美 ,陈晓虎 ,汤粉英 ,唐蜀华 .CHF的神经内分泌激素、细胞因子变化的研究进展[J].医学综述,2004,10(3):146-150. 被引量:17
  • 2Munger MA,Johnson B,Amber IJ,et al.Circulating failure secondary to ischemic or icio-pathic dilated cardiomyopathy.Am J Cardiol,1996:723-727.
  • 3杨晓红,王凤飞,陶桂华,李荣华,祖秀光.心力衰竭时血浆内皮素、一氧化氮及血管紧张素Ⅱ的变化及意义[J].临床心血管病杂志,1998,14(2):114-115. 被引量:39
  • 4王小清,蹇在金,谢景超,王秀华.老年冠心病心衰患者血浆白细胞介素-6和一氧化氮浓度的变化[J].中国现代医学杂志,2001,11(7):58-59. 被引量:11
  • 5Francis GS.Newohumoral activation and progression of heart failwe:hypothetical and clinical considerations.J Cardiovasc Pharmacol,1998,32(Suppl 1):S16-21.
  • 6Mann DL.Recent insights into the role of tumor necrosis factor in the failwe heait.Heart Fail,2001,6:71-80.
  • 7Recchia FA,Bernstein RD,Sehgal PB et al.Cytokines are not a requisite part of the pathophysiology leading to cardiac decompensation.Proc Soc Fxp Biol Med,2000,223:47-52.
  • 8Feldman AM,Combed A,wagnet D,et al.The role of tumor necrosis factor in the pathophysiology of heart failure.J Am Coll Cardiol,2000,35:537-544.
  • 9Bryant D,Backer L,Richardson J,et al.Cardiac failure intransgemc mice with myocardial expression of tumor necrosis factor-a.Circulation,1998,97:1375-1381.
  • 10Tsutamoto T,Hisanaga T,wada A,et al.Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure,and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure.J Am Toll Cardiol,1998,31:391-398.

二级参考文献32

  • 1Ishikawa T, Yanagisawa M, Kimura S, et al. Positive inotropie action of a novel vasoconstrictor peptide endothelin on guinea pig atria[ J]. Am J Physiology, 1988,255 (4 Pt 2 ) : H970-973.
  • 2Shekhar YC, Anand IS, Sarmar R, et al. Effects of prolonged infusion of human Alpha calcitinin gene-related peptid on hemodynamics renal blood flow and hormone levels in C HF[ J]. Am J Cardiol, 1991,67 (8) :732-736.
  • 3Sacca L. Growth hormone :a newcomer in cardiovascular medicine[ J].Cardiovascular Res, 1997,36(1) :3-9.
  • 4Cuneo RC, Wilmshurst P, Lowy C, et al. Cardiac failure responding to growth hormone[J]. Lancet, 1989,1(8642) :838-839.
  • 5Moruzzl P,Dofia E,Agostini PG, et al. Usefulness of L-thyroxin to improve cardiac and exercise performance in idiopathic dilated cardiomyopathy[ J]. Am J Cardiol, 1994,73 (5) : 374-378.
  • 6Kimura T, Kanda T, Kuwabara A, et al. Participation of the pituitarythyroid axis in the cardiovascular system in elderly patients with the CHF[ J] .J Med, 1997,28(1-2) :75-80.
  • 7Martin PY, Abraham WT, Lieming X. Selective v2-receptor vasopressin antagonism decreases urinary aquaporin-2 excretion in patients with CHF[ J] .J Am Soc Nephrol, 1999,10(10) :2165-2170.
  • 8Meldrum DR. Tumor necrosis factor in the heart [ J ]. Am J Physiol,1998,274(3 ) : 577-595.
  • 9Feldman AM, Combes A, Wagner D, et al. The role of tumor necrosis factor in the pathophysiology of heart failure [ J]. J Am Coil Cardiol,2000,35(3) :537-544.
  • 10Finkel MS, Oddis CV, Jacob TD, et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide [ J]. Science, 1992,257(5608) :387-389.

共引文献67

同被引文献43

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部